6126 SARS-CoV-2 S1 IgM

Intended Use:

The AESKULISA SARS-CoV-2 S1 IgM test is a qualitative and quantitative immunoassays for the demonstration of human IgM antibodies in serum or plasma directed against the S1 domain of the spike protein of SARS-CoV-2. The AESKULISA SARS-CoV-2 S1 IgM test assists in the detection of acute infections.

Recombinant Antigens:

Recombinant S1 domain of the spike protein of SARS-CoV-2

Native Antigens:

n.a.